Business | General
Channel Sponsor
J&J reviews global ad planning and buying
Johnson & Johnson, one of the largest US advertising buyers, has decided to review its global media planning and buying, the health care products company said.
- Reuters
- Published: 00:00 April 1, 2007
Los Angeles: Johnson & Johnson, one of the largest US advertising buyers, has decided to review its global media planning and buying, the health care products company said.
The company said it expects to complete the review and have partners in place in time to support 2008 planning.
The media agency review at J&J, which sells products ranging from sugar substitute Splenda to prescription arthritis drug Remicade, does not include the creative side of its advertising, said company spokes-man Mark Monseau.
"The recent acquisition of Pfizer Consumer Healthcare has created an opportunity to reevaluate our media agency relationships and enhance the ability of our brands to effectively communicate and leverage investment across the rapidly changing and increasingly diverse media landscape," he said.
Promotion
The company declined to say how much it spends on average annually on advertising and promotion.
The deal with Pfizer gave New Jersey-based J&J such brands as Listerine mouthwash and the Sudafed allergy drug.
J&J said all of its current media partners - Universal McCann/Initiative, OMD and Mindshare -would participate in the review.
Share this article
More from Business General
More from Business
Popular in Business
-
Budget travel
Airlines in the region
Take a pictorial look at some of the budget airlines in GCC
Business Editor's choice
-
Credit swaps... a fair trade
Would you swap an unbuilt unit at the Lagoons for an apartment at JBR?
-
In pictures: New BMW Z4
The new model is much more user-friendly and driver focused
-
Lebanon realty robust
Overseas Lebanese fuel real estate surge
